You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mammary Neoplasm, Human

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumor, Breast Cancer, Breast Carcinoma Trial in Indianapolis (Enhanced Usual Care, Acceptance Commitment Therapy,

Recruiting
  • Breast Neoplasm
  • +11 more
  • Enhanced Usual Care
  • +2 more
  • Indianapolis, Indiana
    Indiana University-Purdue University Indianapolis
Jul 23, 2022

Mammary Tumor, Human, Periodontal Diseases, Chemo Effect Trial (Non surgical periodontal Treatment)

Completed
  • Mammary Neoplasm, Human
  • +2 more
  • Non surgical periodontal Treatment
  • (no location specified)
Jun 18, 2020

Lactation Trial in Seattle (Cimetidine 200 MG)

Recruiting
  • Lactation
  • Cimetidine 200 MG
  • Seattle, Washington
    University of Washington
Sep 20, 2023

Mammary Tumors, Human Trial in Tianjin (eutidrone etoposide bevacizumab)

Recruiting
  • Mammary Neoplasms, Human
  • eutidrone etoposide bevacizumab
  • Tianjin, Tianjin, China
    Yehui Shi
Mar 10, 2023

Internal Mammary or Supraclavicular Lymphadenectomy

Recruiting
  • Ovarian Cancer Stage IV
  • Lymph Node Metastases
  • debulking surgery
  • Seoul, 시/도/주, Korea, Republic of
    Seoul National University Hospital
Aug 10, 2021

Human Brain-Gut Axis and Gut Microbiome in Brain Lesions -

Not yet recruiting
  • Malignant Central Nervous System Neoplasm
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 31, 2023

Breast Tumors, Breast Cancer, Breast Carcinoma Trial in Indianapolis (Acceptance and Commitment Therapy, Survivorship Education,

Completed
  • Breast Neoplasms
  • +16 more
  • Acceptance and Commitment Therapy
  • +2 more
  • Indianapolis, Indiana
    Indiana University
Jun 25, 2019

Locally Advanced Solid Tumor, Metastatic Tumor Trial in San Antonio (TST003)

Recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Tumor
  • San Antonio, Texas
    NEXT Oncology
Feb 15, 2023

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

Colorectal Cancer, Urologic Cancer, Gynecologic Cancer Trial (acetated Ringers, albumin 5%, albumin 20%)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • acetated Ringers
  • +2 more
  • (no location specified)
Feb 9, 2023

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

Completed
Has Results
  • Breast Cancer
  • Neoplasm Metastasis
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 30, 2022

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Tumor Malignant, Tumor, Experimental, Solid Tumor, Adult Trial in Taipei (JS014, Interleukin 21 and humanized anti-human serum

Active, not recruiting
  • Neoplasm Malignant
  • +3 more
  • JS014, Interleukin 21 and humanized anti-human serum albumin VHH antibody
  • Pembrolizumab - anti-PD-1 antibody
  • Taipei, Taiwan
    Wanfang Hospital -Taipei Medical University
Mar 16, 2022

Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal

Recruiting
  • Spinal Cord Neoplasm
  • Biospecimen Collection
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell Transplant Recipient
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Recombinant Human Papillomavirus Nonavalent Vaccine
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

Recruiting
  • Kidney Cancer
  • +2 more
  • Cytoreductive nephrectomy±metastasectomy
  • Human-derived materials sampling
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 2, 2023

Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma Trial in Sacramento (18F-avß6-BP)

Recruiting
  • Breast Carcinoma
  • +7 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jan 20, 2022

Peritoneal Metastases, Colorectal Cancer Trial in Hangzhou (Hyperthermic intraperitoneal treatment of recombinant modified human

Recruiting
  • Peritoneal Metastases
  • Colorectal Cancer
  • Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Mar 2, 2023

Observational Pilot Study With TachoSil as a Ventricular Sealant

Completed
  • Intraventricular Neoplasm
  • Badalona, Barcelona, Spain
    Hospital Universitari Germans Trias i Pujol
Feb 3, 2023

Colorectal Cancer, Advanced Adenocarcinoma, Hyperplastic Polyp Trial in Jinan (Multigene Methylation Detection Kit)

Completed
  • Colorectal Cancer
  • +5 more
  • Multigene Methylation Detection Kit
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Oct 19, 2022

Cancer in People Living With HIV/AIDS at Cancer Centers in Latin

Active, not recruiting
  • HIV Infection
  • +3 more
  • Medical Chart Review
  • Survey Administration
  • Buenos Aires, Argentina
  • +3 more
Oct 20, 2022

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

Recruiting
  • Cancer
  • +4 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 24, 2023

Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

Not yet recruiting
  • Solid Tumors, Adult
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Jul 21, 2022

Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

Active, not recruiting
  • Human Papillomavirus-16 Positive
  • +20 more
  • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
  • Durvalumab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2022